Prevalence and Antimicrobial Resistance of Campylobacter Species in Diarrheal Patients in Mymensingh, Bangladesh

被引:10
作者
Rahman, Md Ashikur [1 ]
Paul, Priyanka Rani [1 ]
Hoque, Nazmul [1 ]
Islam, Sk Shaheenur [1 ]
Haque, A. K. M. Ziaul [1 ]
Sikder, Mahmudul Hasan [2 ]
Matin, Aminul [3 ]
Yamasaki, Shinji [4 ]
Kabir, S. M. Lutful [1 ]
机构
[1] Bangladesh Agr Univ, Dept Microbiol & Hyg, Mymensingh 2202, Bangladesh
[2] Bangladesh Agr Univ, Dept Pharmacol, Mymensingh 2202, Bangladesh
[3] Bangladesh Agr Univ, Hlth Care Ctr, Mymensingh 2202, Bangladesh
[4] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5988531, Japan
关键词
MULTIPLEX PCR ASSAY; ANTIBIOTIC-RESISTANCE; JEJUNI; IDENTIFICATION; CHILDREN; SUSCEPTIBILITY; DISEASES; POULTRY; DHAKA; SPP;
D O I
10.1155/2021/9229485
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Campylobacter enteritis is the leading cause of gastroenteritis in humans worldwide including Bangladesh. The objectives of this study were to estimate the prevalence and antimicrobial-resistance status of Campylobacter spp. in human diarrheal samples collected from Surya Kanta Hospital, Mymensingh, Bangladesh. In this study, we evaluated a total of 330 clinical samples for the presence Campylobacter spp. via cultural and biochemical tests and molecular assays. Furthermore, antimicrobial susceptibility testing for Campylobacter species was accomplished by the standard agar disc diffusion technique against eight commercially available antimicrobial agents. A pretested semistructured questionnaire was used to capture the data on socioanthropological factors from the diarrheal patients. Pearson's chi-square test was performed, and a p value of Campylobacter spp. Overall prevalence of Campylobacter spp. was estimated to be 31.5% (104/330) that comprised the prevalence of C. jejuni, 21.8% (n=72), and C. coli, 9.6% (n=32). Among the positive cases, the prevalence of Campylobacter was higher in the age group 0-5 years (52%) followed by 6-18 years (42.7%), 19-40 years (34.0%), 41-60 years (25.4%), and >60 years (10.5%). Age, family level's personal hygiene, and involvement with animal husbandry were captured as potential determinants to be associated with the Campylobacter positive status. Among the isolates, 27.3% (n=20) of C. jejuni and 31.2% (n=10) of C. coli demonstrated as multidrug-resistant (MDR) to three or more antimicrobial agents. The present study shows that Campylobacter spp. is most prevalent among the hospital-admitted diarrheal patients, and proper measures should be taken to reduce the burden focusing on the potential determinants.
引用
收藏
页数:9
相关论文
共 55 条
[1]   Bacterial aetiology of diarrhoeal diseases and antimicrobial resistance in Dhaka, Bangladesh, 2005-2008 [J].
Ahmed, D. ;
Hoque, A. ;
Elahi, M. S. B. ;
Endtz, H. P. ;
Hossain, M. A. .
EPIDEMIOLOGY AND INFECTION, 2012, 140 (09) :1678-1684
[2]  
Alam K., 2008, BANGLADESH J MICROBI, V23, P121, DOI [10.3329/bjm.v23i2.875, DOI 10.3329/BJM.V23I2.875]
[3]   Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh [J].
Albert, MJ ;
Faruque, ASG ;
Faruque, SM ;
Sack, RB ;
Mahalanabis, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (11) :3458-3464
[4]   Environmental characteristics associated with campylobacteriosis: accounting for the effect of age and season [J].
Arsenault, J. ;
Michel, P. ;
Berke, O. ;
Ravel, A. ;
Gosselin, P. .
EPIDEMIOLOGY AND INFECTION, 2012, 140 (02) :311-322
[5]   Development of a cytolethal distending toxin (cdt) gene-based species-specific multiplex PCR assay for the detection and identification of Campylobacter jejuni, Campylobacter coli and Campylobacter fetus [J].
Asakura, Masahiro ;
Samosornsuk, Worada ;
Hinenoya, Atsushi ;
Misawa, Naoaki ;
Nishimura, Kazuhiko ;
Matsuhisa, Akio ;
Yamasaki, Shinji .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2008, 52 (02) :260-266
[6]  
Blaser MJ., 1997, J Infect Dis, V176, pS103, DOI DOI 10.1086/513780
[7]  
Boelaert F, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.3991, 10.2903/j.efsa.2015.4302]
[8]  
Centers for Disease Control and Prevention (CDC), 2016, USER GUID, P1
[9]  
Clinical and Laboratory Standards Institute (CLSI), 2016, PERFORMANCE STANDARD, V3rd
[10]   Human campylobacteriosis in developing countries [J].
Coker, AO ;
Isokpehi, RD ;
Thomas, BN ;
Amisu, KO ;
Obi, CL .
EMERGING INFECTIOUS DISEASES, 2002, 8 (03) :237-243